National Health Act 1953 Determination under subsection 85AB(1) and 85AC(1) drugs on F1 and drugs in Part A of F2 (No. PB 95 of 2007) (Cth)

Determination — drugs on F1 and drugs in Part A of F2 (PB 95 of 2007)

as amended

made under subsections 85AB(1) and 85AC(1) of the

National Health Act 1953

This compilation was prepared on 1 August 2010
taking into account amendments up to PB 70 of 2010

Prepared by the Office of Legislative Drafting and Publishing,
Attorney‑General’s Department, Canberra

Determination — drugs on F1 and drugs in Part A of F2 (PB 95 of 2007)

1.         Commencement [see Note 1]

This instrument commences on 1 December 2007.

2.         Drugs on F1

The listed drugs “Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements with phenylalanine and tyrosine and supplemented with docosahexanoic acid”, “Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without methionine and supplemented with docosahexanoic acid”, “Amino acid formula without phenylalanine, and vitamins with minerals”, “Arsenic”, “Certolizumab pegol”, “Dabigatran etexilate”, “Darunavir”, “Erlotinib”, “Essential amino acids formula”, “Exenatide”, “Ganirelix”, “Golimumab”, “High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate”, “Lapatinib”, “Maraviroc”, “Methoxy polyethylene glycol-epoetin beta”, “Nevirapine”, “Nicotine”, “Nilotinib”, “Praziquantel”, “Rivaroxaban”, “Sevelamer”, “Sitagliptin”, “Soy lecithin”, “Telbivudine”, “Tocilizumab”, “Vildagliptin”, “Vitamins, minerals and trace elements with carbohydrate” and “Zonisamide” areon F1.

3.         Drugs on F2

The listed drugs “Alendronic acid with colecalciferol”, “Azithromycin”, “Bicalutamide”, “Bisoprolol”, “Cabergoline”, “Cefalotin”, “Clopidogrel”, “Enalapril with hydrochlorothiazide”, “Famciclovir”, “Fludarabine”, “Galantamine”, “Gemcitabine”, “Glucose”, “Levetiracetam”, “Memantine”, “Morphine”, “Naltrexone”, “Octreotide”, “Risperidone”, “Sodium chloride”, “Sodium lactate compound”, “Sorbitol with sodium citrate and sodium lauryl sulfoacetate”, and “Topiramate” are on F2.

4.         Drugs in Part A of F2

“Alendronic acid with colecalciferol”, “Azithromycin”, “Bicalutamide”, “Bisoprolol”, “Cabergoline”, “Cefalotin”, “Clopidogrel”, “Enalapril with hydrochlorothiazide”, “Famciclovir”, “Fludarabine”, “Galantamine”, “Gemcitabine”, “Glucose”, “Levetiracetam”, “Memantine”, “Morphine”, “Naltrexone”, “Octreotide”, “Risperidone”, “Sodium chloride”, “Sodium lactate compound”, “Sorbitol with sodium citrate and sodium lauryl sulfoacetate”, and “Topiramate” are in Part A of F2.

Notes to the Determination — drugs on F1 and drugs in Part A of F2 (PB 95 of 2007)

Note 1

The Determination — drugs on F1 and drugs in Part A of F2 (PB 95 of 2007) (in force under subsections 85AB(1) and 85AC(1) of the National Health Act 1953) as shown in this compilation is amended as indicated in the Tables below.

Table of Instruments

Title	Date of FRLI Registration	Date of commencement	Application, saving or transitional provisions
PB 95 of 2007	16 Nov 2007 (see F2007L04367)	1 Dec 2007
PB 97 of 2007	30 Nov 2007 (see F2007L04577)	(a)	—
PB 47 of 2008	15 Apr 2008 (see F2008L01039)	1 May 2008	—
as amended by
PB 57 of 2008	19 Apr 2008 (see F2008L01167)	(b)	—
PB 83 of 2008	25 July 2008 (see F2008L02622)	1 Aug 2008	—
PB 117 of 2008	27 Nov 2008 (see F2008L04415)	1 Dec 2008	—
PB 28 of 2009	20 Mar 2009 (see F2009L01119)	1 Apr 2009	—
PB 66 of 2009	17 July 2009 (see F2009L02715)	1 Aug 2009	—
PB 89 of 2009	17 Sept 2009 (see F2009L03540)	1 Oct 2009	—
PB 2 of 2010 (c)	20 Jan 2010 (see F2010L00152)	21 Jan 2010	—
PB 25 of 2010	17 Mar 2010 (see F2010L00684)	1 Apr 2010	—
PB 47 of 2010	26 May 2010 (see F2010L01378)	1 June 2010	—
PB 70 of 2010	16 July 2010 (see F2010L02061)	1 Aug 2010	—

(a)    Section 1 of PB 97 of 2007 provides as follows:

This instrument commences at 8pm on 30 November 2007.

The effect was to amend the text of PB 95 before the latter’s commencement.

(b)    Section 1 of PB 57 of 2008 provides as follows:

This instrument commences at 8.00 pm on 30 April 2008.

(c)     The National Health Act 1953 — Amendment determination under subsections 85AB(1) and 85AC(1) – drugs on F1 and drugs in Part A of F2 (No. PB 2 of 2010) was disallowed by the Senate on 11 March 2010.

Table of Amendments

ad. = added or inserted      am. = amended      rep. = repealed      rs. = repealed and substituted
Provision affected	How affected
S. 2..................................................	am. PB 47, 83 and 117 of 2008; PB 28 and 66 of 2009; PB 25 and 70 of 2010
S. 3..................................................	am. PB 97 of 2007; PB 47, 83 and 117 of 2008; PB 28, 66 and 89 of 2009; PB 25, 47 and 70 of 2010
S. 4..................................................	am. PB 97 of 2007; PB 47, 83 and 117 of 2008; PB 28, 66 and 89 of 2009; PB 25, 47 and 70 of 2010